论文部分内容阅读
本月全球药品研发进展取得成效的药物有50个,较上月增加了7个,除进入Ⅲ期临床阶段的药品数量略有减少外,进入其他研发阶段的药品数量均有所增加。进入注册阶段的有22个,比上月大幅增加7个。
There were 50 drugs that made progress in global drug development this month, an increase of 7 over the previous month. The number of drugs entering other R & D phases increased except for the slight decrease in the number of drugs entering the phase III clinical phase. 22 have entered the registration phase, a substantial increase of 7 from the previous month.